Literature DB >> 3164315

Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation.

G M Rodgers1, W H Kane, R E Pitas.   

Abstract

Vascular cell procoagulant activity may be important in the pathogenesis of atherosclerosis. In previous studies, we described the ability of the atherogenic metabolite homocysteine to activate endothelial cell Factor V, a key coagulation cofactor for thrombin generation. The present study was designed to investigate Factor V activity and Factor Xa-catalyzed prothrombin activation by control and atherosclerotic aorta from normal and hypercholesterolemic rabbits. Factor Xa generated ninefold more thrombin on atherosclerotic aortic segments than on control segments. Atherosclerotic segments activated 125I-prothrombin with Factor Xa in the presence of the thrombin inhibitor dansyl arginine-4-ethylpiperidine amide and cleaved 125I-Factor V. This suggests that increases in vessel-wall Factor V activity and Factor Xa-catalyzed prothrombin activation result from activation of vessel-wall Factor V. 125I-Factor Va peptides generated by atherosclerotic aorta were very similar in molecular weight to those generated by homocysteine-treated cells. When vascular endothelium was mechanically removed by brushing, atherosclerotic vessels still generated four- to fivefold more thrombin than control vessels. These data and results from immunocytochemical studies suggest that Factor V in atherosclerotic vessels is associated with both endothelium and other cells of the lesion. In contrast, Factor V in control vessels is associated primarily with endothelium. The increases in Factor V activity and thrombin formation in the blood vessel wall of hypercholesterolemic rabbits may contribute to the development of atherosclerosis and its complications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164315      PMCID: PMC442643          DOI: 10.1172/JCI113538

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 2.  Epidemiology of coronary heart disease.

Authors:  J Stamler
Journal:  Med Clin North Am       Date:  1973-01       Impact factor: 5.456

3.  Polyethylene glycol 6,000 enhancement of the clotting of fibrinogen solutions in visual and mechanical assays.

Authors:  J W Fenton; M J Fasco
Journal:  Thromb Res       Date:  1974-06       Impact factor: 3.944

4.  Deposition of modified fibrinogen within the aortic intima.

Authors:  J R Shainoff; I H Page
Journal:  Atherosclerosis       Date:  1972 Nov-Dec       Impact factor: 5.162

5.  Experimental models of human atherosclerosis.

Authors:  R W Wissler; D Vesselinovitch
Journal:  Ann N Y Acad Sci       Date:  1968-11-21       Impact factor: 5.691

6.  LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells.

Authors:  D P Baker; B J Van Lenten; A M Fogelman; P A Edwards; C Kean; J A Berliner
Journal:  Arteriosclerosis       Date:  1984 May-Jun

7.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.

Authors:  D W Morel; J R Hessler; G M Chisolm
Journal:  J Lipid Res       Date:  1983-08       Impact factor: 5.922

8.  Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery.

Authors:  R Ross; T N Wight; E Strandness; B Thiele
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

9.  Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.

Authors:  G M Rodgers; M A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro.

Authors:  M Laposata; D K Dovnarsky; H S Shin
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

View more
  2 in total

1.  Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.

Authors:  Heather K Kroh; Peter Panizzi; Svetlana Tchaikovski; T Regan Baird; Nancy Wei; Sriram Krishnaswamy; Guido Tans; Jan Rosing; Bruce Furie; Barbara C Furie; Paul E Bock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

2.  Perspective on the hospital incidence rate of deep venous coagulopathy: Clinical and biochemical diagnostic markers.

Authors:  Alireza Khosravi; Mojgan Gharipour; Morteza Abdar Isfahani; Hamid Mohajeri; Mohammad Saadatnia; Farshad Roghani; Shahin Shirani; Arsalan Khaledifar
Journal:  Adv Biomed Res       Date:  2014-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.